Brief: Longeveron Inc Reports First Quarter 2023 Financial Results

Longeveron

12/05/2023 13:40

May 12 (Reuters) - Longeveron Inc  LGVN.O :
    * LONGEVERON INC. PROVIDES CORPORATE UPDATE AND REPORTS
FIRST
QUARTER 2023 FINANCIAL RESULTS
    * LONGEVERON INC Q1 LOSS PER SHARE $0.22
    * LONGEVERON INC - FIRST PATIENT DOSED IN PHASE 2 CLINICAL
TRIAL
OF LOMECEL-B(TM) FOR AGING-RELATED FRAILTY IN JAPAN
    * LONGEVERON - BELIEVE EXISTING CASH AND SHORT-TERM
INVESTMENTS
WILL BE SUFFICIENT TO COVER EXPENSES AND CAPITAL REQUIREMENTS
INTO Q2 OF 2024
    * LONGEVERON INC - CASH AND SHORT-TERM INVESTMENTS WAS $13.7
MILLION AS OF MARCH 31

Source text for Eikon:  ID:nGNX7jSz1y 
Further company coverage:  LGVN.O 

 ((Reuters.Briefs@thomsonreuters.com;))